Abstract:Key Points: The efficacy of acute peritoneal dialysis is still controversial.There was no significant difference in 28-day mortality between acute peritoneal dialysis and intermittent hemodialysis. Background: Lower delivered dose of acute peritoneal dialysis (PD) in AKI requires less resources but raises concerns regarding adequate solute and water clearance. The relative merits of lower-dose PD versus intermittent hemodialysis remain uncertain. Methods: A multicenter randomized controlled trial compared the outcomes between acute lower-dosage PD (18–24 L per day) and intermittent hemodialysis (three times per week) from May 2018 to January 2021 in patients with AKI. The primary outcome was 28-day mortality rate. Secondary outcomes included 28-day dialysis-free survival and kidney recovery, metabolic profile, and procedure-related complications. Noninferiority of PD to hemodialysis would be demonstrated if the upper bound of the 95% confidence interval ( CI) on risk difference (PD-hemodialysis) in 28-day mortality rates between the two groups was <20%. Results: We included 157 patients (80 allocated to PD and 77 to intermittent hemodialysis). Before KRT initiation, baseline clinical characteristics between groups were comparable. The overall mean age was 57±15 years. The most frequent cause of AKI was sepsis (68%). There was no difference in 28-day mortality between acute PD and intermittent hemodialysis (50% versus 49%, risk difference 0.6 [95% CI, −15.0 to 16.3]), and 28-day dialysis-free survival (42% versus 37%, risk difference 4.6 [95% CI, −11.1 to 20.3]). Mean weekly Kt/V urea was 2.11±1.14 and 2.55±1.11 in the PD and intermittent hemodialysis groups, respectively. The 7-day fluid balance of PD and intermittent hemodialysis patients was not significantly different. There was more frequent intradialytic hypotension in the intermittent hemodialysis group and more frequent hypokalemia in the PD group. Conclusions: In this study of patients with AKI, there was no significant difference in 28-day mortality between acute PD and intermittent hemodialysis.

Application of peritoneal dialysis in acute kidney injury

Peritoneal Dialysis Treatment Modality Option in Acute Kidney Injury

Use of Peritoneal Dialysis in Acute Kidney Injury: How Far Away?

Recent Advances in Engineered Nanomaterials for Acute Kidney Injury Theranostics

Peritoneal Dialysis in Renal Replacement Therapy for Patients with Acute Kidney Injury

New applications of automated peritoneal dialysis

Updates in Timing of Initiation of Renal Replacement Therapy in Patients with Acute Kidney Injury

Urgent Start Peritoneal Dialysis: A Viable Option for Acute and Chronic Kidney Failure

Peritoneal dialysis and acute kidney injury in acute brain injury patients

Peritoneal dialysis for the management of pediatric patients with acute kidney injury

Acute kidney injury: Epidemiology, outcomes, complications, and therapeutic strategies

Long-term Renal and Overall Survival of Critically Ill Patients with Acute Renal Injury Who Received Continuous Renal Replacement Therapy.

Acute kidney injury. the need for renal replacement therapy and complications during the application

Local Renal Treatments for Acute Kidney Injury: A Review of Current Progress and Future Translational Opportunities

Renal replacement therapy: a practical update

Acute Peritoneal Dialysis is an Efficient and Reliable Alternative Therapy in Preterm Neonates with Acute Kidney Injury

The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function

Application of nanotechnology in acute kidney injury: From diagnosis to therapeutic implications

Recent Advances in Nanotherapeutics for the Treatment and Prevention of Acute Kidney Injury

Lower-Dosage Acute Peritoneal Dialysis versus Acute Intermittent Hemodialysis in Acute Kidney Injury: A Randomized Controlled Trial

Past, Current, and Future Perspectives on Transplanting Acute Kidney Injury Kidneys